450
F.E. McDonald, K.S. Reddy / Journal of Organometallic Chemistry 617–618 (2001) 444–452
solution of EtOAc (0.5 ml) and stirred for an additional
30 min at low temperature. The mixture was then
poured into a cold solution of 1M aqueous HCl (30
ml). Extractive workup (EtOAc–H2O) and silica gel
chromatography (n-hexanes–EtOAc, 19:1) afforded
compound 23 (129 mg, 74%). [a]2D3 +18.7 (CHCl3, C,
2.11); IR (neat): 3534, 3306, 3071, 3049, 2957, 2932,
[a]2D3 +27.6 (CHCl3, C, 1.35); IR (neat): 3582, 3306,
1
3071, 3049, 2931, 1427, 1111, 701 cm−1; H-NMR (600
MHz, CDCl3): l 7.76–7.75 (m, 2H), 7.73–7.71 (m,
2H), 7.55–7.53 (m, 2H), 7.49–7.48 (m, 2H), 7.43–7.20
( series of m, 22H), 5.48 (d, J=8.4 Hz, 1H), 4.64 (d,
J=3.0 Hz, 1H), 4.55 (dd, J=4.2, 2.4 Hz, 1H), 4.15
(app. q, J=6.6 Hz, 1H), 3.81 (app. sextet, J=4.2 Hz,
1H), 3.78 (d, J=8.4 Hz, 1H), 3.60 (app. q, J=6.6 Hz,
1H), 3.50 (d, J=3.0 Hz, 1H), 2.66 (d, 4.2 Hz, 1H), 2.43
(d, J=1.8 Hz, 1H), 1.25 (br, s, 1H), 1.23 (d, J=6.0
Hz, 3H), 1.10 (s, 9H), 1.00 (s, 9H), 0.97 (s, 9H), 0.69 (d,
J=7.2 Hz, 3H). 13C-NMR (150 MHz, CDCl3): l 136.3,
136.0, 135.9, 135.9, 135.8, 133.6, 133.0, 132.9, 132.8,
132.7, 129.9, 129.9, 129.8, 129.7, 129.7, 127.8, 127.7,
127.6, 127.6, 127.5, 98.9, 80.0, 79.9, 76.7, 74.4, 69.4,
69.1, 28.0,.27.2, 27.0, 26.9, 19.6, 19.10, 19.0, 18.9.
HRMS (FAB+) Anal. Calc. for C60H73ILiO6Si3 [(M+
Li)+] 1107.3920. Found 1107.3866. Anal. Calc. for
C60H73O6Si3 C, 66.75; H, 6.44. Found C, 65.63; H,
6.68%.
2859, 1427, 1110, 1033, 703 cm−1 1H-NMR (400
;
MHz, CDCl3): l 7.79–7.23 (series of m, 30H), 5.07 (d,
J=7.6 Hz, 1H), 4.98 (app. dd, J=5.0, 2.0 Hz, 1H),
4.48 (d, J=3.6 Hz, 1H), 4.39 (app. q, J=6.4 Hz, 1H),
3.73 (d, J=8.0 Hz, 1H), 3.67 (br, s, 1H), 3.55 (d,
J=3.2 Hz, 1H), 3.35–3.30 (m, 2H), 2.39 (d, J=1.6 Hz,
1H), 1.43 (d, J=6.0 Hz, 1H), 1.11 (s, 9H), 1.05 (s, 9H),
0.91 (s, 9H), 0.47 (d, J=6.8 Hz, 3H); 13C-NMR (100
MHz, CDCl3): l 136.1, 135.9, 135.8, 135.7, 133.2,
132.9, 132.9, 132.6, 132.6, 132.1, 130.0, 130.0, 129.8,
129.6, 127.8, 127.8, 127.7, 127.6, 127.5, 104.7, 82.6,
81.6, 79.7, 79.1, 75.1, 74.2, 68.5, 67.5, 67.6, 28.1, 27.1,
26.9, 26.8, 19.9, 19.8, 19.2, 19.0, 18.9; HRMS (FAB+)
Anal. Calc. for C60H73ILiO6Si3 [(M+Li)+] 1107.3920.
Found 1107.3933. Anal. Calc. for C67H77IO7Si3, C,
66.76; H, 6.44. Found C, 67.02; H, 6.70%.
4.6.3. Preparation of alkynyl alcohol (25)
The procedure for 25 is essentially the same as de-
scribed for 24 (Section 4.6.2) except tert-
butyldimethylsilyl chloride was used instead of
TBDPSCl. Thus a mixture of 20 (135 mg, 0.14 mmol),
imidazole (45 mg, 0.66 mmol), tert-butyldimethylsilyl
chloride (32 mg, 0.21 mmol), and DMF (2 ml) was
stirred for 48 h to give O-TBS protected product (141
mg, 94%). IR (neat): 3306, 3071, 3049, 2930, 1719,
4.6.2. Preparation of alkynyl alcohol (24)
Glycoside 20 (205 mg, 0.21 mmol) and imidazole (72
mg, 1.1 mmol) were dissolved in dry DMF (2 ml), and
tert-butyldiphenylsilyl chloride (110 ml, 0.42 mmol) was
added. The resulting mixture was stirred for 48 h and
then quenched with water (1 ml). The reaction mixture
was diluted with EtOAc (100 ml), washed with water
(20 ml), brine (20 ml), dried over Na2SO4, and then
concentrated under reduced pressure to give the crude
product. The mixture was purified by silica gel chro-
matography (gradient elution 98:2–19:1, n-hexanes–
EtOAc) to afford O-TBDPS protected product (212
mg, 83%) as a white solid. M.p. 62–64°C; [a]2D3 −6.95
(CHCl3, C, 3.2); IR (neat): 3304, 3071, 2931, 2858,
1
1276, 1111, 702 cm−1; H-NMR (400 MHz, CDCl3): l
8.07–8.05 (m, 2H), 7.58–7.18 (series of m, 23H), 5.64
(d, J=8.4 Hz, 1H), 5.61 app. sextet, J=7.2, 2.4 Hz,
1H), 4.18 (dd, J=7.4, 2.4 Hz, 1H, 3.92, (d, J=8.0 Hz,
1H), 3.70 (app. q, J=7.2 Hz, 1H), 3.50 (d, J=2.8 Hz,
1H), 1.40 (d, J=6.8 Hz, 1H), 1.04 (s, 9H), 1.00 (s, 9H),
0.93 (s, 9H), 0.68 (d, J=6.8 Hz, 1H), 0.14 (s, 3H), 0.07
(s, 3H); 13C-NMR (100 MHz, CDCl3): l 165.9, 136.1,
136.0, 135.9, 135.8, 133.1, 133.0, 132.7, 132.7, 130.6,
129.9, 129.8, 129.7, 128.2, 127.8, 127.6, 127.5, 98.8,
79.8, 79.5, 78.6, 75.43, 74.3, 72.4, 68.9, 28.4, 27.1, 27.0,
25.9, 19.6, 19.0, 18.9, 18.3, 14.1, −3.6, −4.8; HRMS
(FAB+) Anal. Calc. for C60H73ILiO6Si3 [(M+Li)+]
1087.3869. Found 1087.3821. The benzoate ester of this
product was removed by DiBAL-H reduction as de-
scribed for 23 (Section 4.6.1), to provide compound 25
(114 mg, 89%). IR (neat): 3568, 3480, 3307, 3071, 3049,
1
1717, 1427, 1274, 1111, 1032, 702 cm−1; H-NMR (400
MHz, CDCl3): l 7.77–7.19 (series of m, 35H), 5.57
(app. br. d, J=8.4 Hz, 1H), 4.73 (app. d, J=2.8 Hz,
1H), 4.55 (dd, J=6.2, 2.0 Hz, 1H), 4.18 (dd, J=6.2,
2.0 Hz, 1H), 3.88 (d, J=8.0 Hz, 1H), 3.61 (app. q,
J=6.8 Hz, 1H), 3.48 (d, J=3.6 Hz, 1H), 2.48 (d,
J=2.0 Hz, 1H), 1.58 (d, J=6.8 Hz, 3H), 1.12 (s, 9H),
1.04 (s, 9H), 1.00 (s, 9H), 0.67 (d, J=6.4 Hz, 3H);
13C-NMR (100 MHz, CDCl3): l 165.6, 136.5, 136.2,
136.1, 136.1, 135.9, 135.9, 135.8, 133.1, 133.0, 132.9,
132.8, 132.7, 132.4, 130.5, 129.8, 129.7, 129.6, 129.4,
127.9, 127.8, 127.7, 127.6, 127.5, 127.4, 127.4, 98.9,
79.8, 79.7, 78.9, 77.4, 75.6, 74.4, 72.2, 68.6, 28.2, 27.2,
27.0, 19.6, 19.0, 18.9, 14.9. HRMS (FAB+) Anal. Calc.
for C67H77ILiO7Si3 [(M+Li)+] 1211.4182. Found
1211.4207. The benzoate ester of this product was
removed by DIBAL-H reduction as described for 23, to
provide compound 24 (192 mg, 100%). M.p. 55–60°C;
2930, 2858, 1471, 1427, 1110, 1084, 1032, 702 cm−1
;
1H-NMR (400 MHz, CDCl3): l 7.58–7.19 (series of m,
20H), 5.64 (d, J=8.4 Hz, 1H), 4.72 (d, J=3.2 Hz, 1H),
4.55 (d, J=4.0, 2.0 Hz, 1H), 4.13 (app. quintet, J=6.4
Hz, 1H), 3.88 (d, J=8.0 Hz, 1H), 3.76 (d, J=5.6 Hz,
1H), 3.74 (app. q, J=6.0 Hz, 1H), 3.55 (d, J=2.8 Hz,
1H), 2.52 (d, J=2.4 Hz, 1H), 1.22 (d, J=6.4 Hz, 3H),
1.04 (s, 9H), 0.99 (s, 9H), 0.92 (s, 9H), 0.74 (d, J=6.8
Hz, 3H), 0.16 (s, 3H), 0.13 (s, 3H); 13C-NMR (100